Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0

Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0

Immunotherapy (IT) in the form of monoclonal antibodies targeting coreceptors involved in the modulation of the immune synapse represents a standard of care for patients with distinct malignancies. Over the past years, evidences supporting the clinical use of IT both in monotherapy, as well as in co...

Full description

Saved in:
Bibliographic Details
Main Authors: Rodrigo Ramella Munhoz, Clarissa Maria de Cerqueira Mathias, Guilherme Harada, Aknar Calabrich, Alberto Julius Wainstein, Andréia Cristina de Melo, Antonio Carlos Buzaid, Artur Katz, Carlos Gil Ferreira, Carlos Henrique dos Anjos, Clarissa Baldotto, Elimar Elias Gomes, Fernando Moura, Gilberto de Castro, Guilherme Nader Marta, Gustavo dos Santos Fernandes, Luiza Dib Batista Bugiato Faria, Mariana Laloni, Paulo Marcelo Gehm Hoff, Romualdo Barroso-Sousa, Sergio Jobim de Azevedo, Vladmir Cláudio Cordeiro de Lima, William Nassib William
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2022-10-01
Series:Brazilian Journal of Oncology
Subjects:
immunotherapy
practice guideline
adverse effects
immune-checkpoint inhibitors
Online Access:https://www.brazilianjournalofoncology.com.br/details/197/en-US/updated-brazilian-guidelines-for-the-management-of-immune-related-adverse-events-associated-with-checkpoint-inhibitors---edition-2-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.brazilianjournalofoncology.com.br/details/197/en-US/updated-brazilian-guidelines-for-the-management-of-immune-related-adverse-events-associated-with-checkpoint-inhibitors---edition-2-0

Similar Items